Correlation Between Immutep and Rigel Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Immutep and Rigel Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immutep and Rigel Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Immutep Ltd ADR and Rigel Pharmaceuticals, you can compare the effects of market volatilities on Immutep and Rigel Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immutep with a short position of Rigel Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immutep and Rigel Pharmaceuticals.

Diversification Opportunities for Immutep and Rigel Pharmaceuticals

-0.23

Correlation Coefficient

Immutep  Rigel Pharmaceuticals

Very good diversification

The 3 months correlation between Immutep and Rigel is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Immutep Ltd ADR and Rigel Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rigel Pharmaceuticals and Immutep is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immutep Ltd ADR are associated (or correlated) with Rigel Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rigel Pharmaceuticals has no effect on the direction of Immutep i.e., Immutep and Rigel Pharmaceuticals go up and down completely randomly.

Pair Corralation between Immutep and Rigel Pharmaceuticals

Given the investment horizon of 90 days Immutep Ltd ADR is expected to under-perform the Rigel Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Immutep Ltd ADR is 1.95 times less risky than Rigel Pharmaceuticals. The stock trades about -0.07 of its potential returns per unit of risk. The Rigel Pharmaceuticals is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,647  in Rigel Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  141.00  from holding Rigel Pharmaceuticals or generate 8.56% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Immutep Ltd ADR  vs.  Rigel Pharmaceuticals

Immutep Ltd ADR

Risk-Adjusted Performance

Very Weak

Over the last 90 days Immutep Ltd ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's primary indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Rigel Pharmaceuticals

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Rigel Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite quite unfluctuating technical and fundamental indicators, Rigel Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Immutep and Rigel Pharmaceuticals

The main advantage of trading using opposite Immutep and Rigel Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immutep position performs unexpectedly, Rigel Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rigel Pharmaceuticals will offset losses from the drop in Rigel Pharmaceuticals' long position.

The idea behind Immutep Ltd ADR and Rigel Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.